Blogs

Blogs

ASCOconnection.org is a forum for the exchange of views on topical issues in the field of oncology. The views expressed in the blogs, comments, and forums belong to the authors. They do not necessarily reflect the views or positions of the American Society of Clinical Oncology. Please read the Commenting Guidelines.

No Results.

Inequalities, especially in health care, breed discontent. We need better ways to continue incentivizing the development of new drugs while optimizing access. Biosimilars help, but they won't solve the whole problem.
Dr. Nagi S. El Saghir shares highlights from the 11th annual Best of ASCO Lebanon, attended by more than 300 medical professional from the country and surrounding region.
ASCO CEO Dr. Clifford Hudis describes the Society's Global Oncology programs and the initiatives of the Global Oncology Leadership Task Force. Dr. Hudis asks challenging questions about providing optimal cancer care in low-income countries. 
The region has seen structural reforms in health care systems, better training of cancer professionals, new initiatives for populations at high risk, expansion of cancer registries and cancer plans, and implementation of policies to improve prevention, early diagnosis, and treatment.
Follow-on biologics are here to stay, and represent enormous potential for patients with cancer being treated in low- and middle-income countries.
This is the story of how, like Mr. Smith in Washington, the medical community in Brazil gathered to speak truth to power about the lack of evidence for phosphoethanolamine as a cancer treatment.
Many issues and opportunities require the collective wisdom of the oncology community, but perhaps none are more challenging than those faced by many of our colleagues around the world, as the global burden of cancer will be magnified by the aging of the population.
A letter from Gabriel N. Hortobagyi, MD, FACP, FASCO, Chair of ASCO's Global Oncology Leadership Task Force.
I have had a wonderful experience working with ASCO’s International Cancer Corps to start the Bhutan cancer registry.
This is the story of how a populist Congress approved the medication that wasn't, and oncologists in the country are waiting to see if an enfeebled president will be able to veto the bill.
Dr. Nagi El Saghir reflects on the challenges of delivering cancer care in regions rocked by hostilities, but sees hope in impactful educational and scientific meetings such as the recent Beirut Breast Cancer Conference (BBCC-4).
This is the story of how an eager chemistry professor and a well-intended but misguided federal judge transformed cancer care and drug development in Brazil into a convoluted soap opera.
ASCO CEO Dr. Allen S. Lichter reflects on an optimistic approach to the challenges of providing high-quality cancer care around the globe on World Cancer Day.
The decision to scale up the provision of oral chemotherapy was a watershed event in the regulation of private health insurance in Brazil; however, prospects for expanded access to such medicines in the public health system are bleak in the short term.
Dr. Fredrick Chite Asirwa illustrates that every person in the clinic has an impact on patients.
There are so many myths about cancers and their causation that may be detrimental to cancer control efforts, especially in sub-Saharan Africa, Dr. Fredrick Chite Asirwa explains.
When a group of medical students approached Dr. Frederick Chite Asirwa to help lead their efforts towards cancer awareness in various schools in Western Kenya, he gladly agreed.
Dr. Julie Gralow is excited to be participating in Union for International Cancer Control World Cancer Day events along with more than 500 Nigerian patients, survivor advocates, health care providers, government officials, students, and parents.

Pages